Is DSIP Legal? FDA, Compounding and WADA Status
DSIP's FDA status, compounding rules and anti-doping status, with a dated timeline of every change we track.
- FDA status
- Not approved
- Off Category 2, 15 Apr 2026
- PCAC vote
- Not recommended
- Jul 2026, not final
- WADA
- Unclear
- Not named on the 2026 list
Current status
PCAC did not recommend (Jul 2026)No. DSIP is not FDA approved for any use. The FDA removed it from Category 2 on 15 Apr 2026. Its advisory committee did not recommend it for the 503A compounding list in July 2026.
| Country | Status | Source |
|---|---|---|
| United States | No approved product foundNo FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "DSIP" returned no matches on 2 Oct 2026. | api.fda.govchecked 2 Oct 2026 |
Timeline
- Advisory committee backs 6 of 7 peptides for the 503A listPCAC vote
- FDA gives notice that 12 peptides will be removed from Category 2 (nominations withdrawn)FDA
Compounding and research-use sellers
- Category 2 is the FDA's list of bulk substances it flagged as raising significant safety concerns. Compounding pharmacies are not expected to compound from them while they are on it.
- The Pharmacy Compounding Advisory Committee (PCAC) advises the FDA on which substances belong on the 503A bulks list that pharmacies may compound from. Its votes are advice; the FDA decides.
- "Research use only" products are sold outside these rules and are not checked by the FDA for identity, purity or dose.
- DSIP was removed from Category 2 on 15 Apr 2026. Removal is not approval.
FDA compounding record: DSIP (emideltide) was removed from FDA's 503A category 2 after the nominators withdrew; FDA announced a PCAC consultation on 24 July 2026. · fda.gov, checked 2 Oct 2026
Sport and drug testing
WADA status unclearDSIP: This is not named on the 2026 list. The catch-all class S0 prohibits any drug with no approval anywhere for human use, so it would be banned if no health authority has approved it, but we have not verified that for this substance.
Outside the US
Rules differ by country. What each regulator's own records show, with the date we checked:
| Country | Status | Source |
|---|---|---|
| United Kingdom | No approved product foundNo approved product found in an emc (UK SmPC compendium) search for "DSIP" on 2 Oct 2026. | medicines.org.ukchecked 2 Oct 2026 |
| Canada | No approved product foundNo product found in a Health Canada Drug Product Database search for ingredient "DSIP" on 2 Oct 2026. | health-products.canada.cachecked 2 Oct 2026 |
| Australia | No approved product foundNo approved product found in an ARTG search for "emideltide" on 2 Oct 2026. | tga.gov.auchecked 2 Oct 2026 |
| European Union | No centrally authorised EU medicine foundEMA medicines list, searched 2 Oct 2026 | ema.europa.euchecked 2 Oct 2026 |
What FDA has said about emideltide (DSIP) for compounding
FDA's safety-risk list for compounding says emideltide may carry immunogenicity and impurity risks.[12]
For its July 2026 advisory committee meeting, FDA listed emideltide-related bulk drug substances among those being considered for the 503A Bulks List.[13]
The committee's voting questions asked separately whether emideltide free base and emideltide acetate should be placed on the list.[14]
FDA's briefing slides state that neither emideltide form is a component of an FDA-approved drug.[15]
The same slides record that the nominations were withdrawn and that FDA is evaluating the substances at its own discretion.[15]
Searches of other regulators
The Health Canada Drug Product Database returned zero active-ingredient records for DSIP.[7]
The UK emc compendium search for DSIP returned no results.[6]
The Australian ARTG search for emideltide found no matching results.[8]
The cached EMA medicines export search for DSIP found no matching rows.[9]
Common questions
Is DSIP FDA approved?
FDA says neither emideltide form is a component of an approved drug.[15]
Is DSIP legal to buy?
It is not an approved drug. Online sellers label it "for research use only, not for human use"; the FDA sent warning letters to five such sellers on 24 Aug 2026. Whether a pharmacy may compound it depends on its FDA bulk-substance status. Rules differ by country.
Is DSIP banned by WADA?
It is unclear. DSIP: This is not named on the 2026 list. The catch-all class S0 prohibits any drug with no approval anywhere for human use, so it would be banned if no health authority has approved it, but we have not verified that for this substance.
Is DSIP legal to compound?
FDA's slides record that the nominations were withdrawn and the substance is being evaluated at FDA's discretion, which is not a permission.[15]
More on DSIP
Sources
- 1Certain bulk drug substances for use in compounding that may present significant safety risks (Category 2; 'nominated but withdrawn' table, content current as of 22 Apr 2026)U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
- 2Pharmacy Compounding Advisory Committee meeting, 23–24 Jul 2026 (agenda and materials)U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
- 3World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
- 4United States: No FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "DSIP" returned no matches on 2 Oct 2026.U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
- 5US compounding: DSIP (emideltide) was removed from FDA's 503A category 2 after the nominators withdrew; FDA announced a PCAC consultation on 24 July 2026.U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
- 6United Kingdom: No approved product found in an emc (UK SmPC compendium) search for "DSIP" on 2 Oct 2026.Electronic Medicines Compendium (UK) · 2026medicines.org.ukAccessed 2 Oct 2026
- 7Canada: No product found in a Health Canada Drug Product Database search for ingredient "DSIP" on 2 Oct 2026.Health Canada · 2026health-products.canada.caAccessed 2 Oct 2026
- 8Australia: No approved product found in an ARTG search for "emideltide" on 2 Oct 2026.Therapeutic Goods Administration (Australia) · 2026tga.gov.auAccessed 2 Oct 2026
- 9EMA medicines export (centrally authorised medicines) (searched 2 Oct 2026)European Medicines Agency · 2026ema.europa.euAccessed 2 Oct 2026
- 10Advisory committee backs 6 of 7 peptides for the 503A listNCPA · 2026ncpa.org
- 11FDA gives notice that 12 peptides will be removed from Category 2 (nominations withdrawn)FDA · 2026fda.govAccessed 2 Oct 2026
- 12Official web pageOfficial web page · web page
- 13Official web pageOfficial web page · web page
- 14Official web pageOfficial web page · web page
- 15Official web pageOfficial web page · web page
Found an error? Report a correction.